NightHawk Biosciences announced its Scorpius BioManufacturing subsidiary (?Scorpius?) has commenced work on a contract that it was awarded by a leading university to develop and manufacture a novel biologic targeting substance use disorder, which includes drug, alcohol and opioid addiction.